168 Ornidazole has been loaded on hydrogels composed of CMCh for colon-targeted delivery, and its release can be controlled by a change in pH
10.3389/fendo.2019.00260 [DOI] [PMC free article] [PubMed] [Google Scholar] Holt, M
GLP-1 receptor agonists and the path to sustainable obesity care
39 The pre-specified primary objective of this meta-analysis was the comparison of the time to the first occurrence of confirmed 4-component MACEs (MACE-4) (i.e., cardiovascular death, myocardial infarction, stroke, and hospitalization for unstable angina) between the pooled tirzepatide and control groups
The phase 3 ESSENCE trial, a multicenter, randomized, double-blind, placebo-controlled study, included 1197 patients with biopsy-confirmed MASH and F2-F3 fibrosis, of whom 800 were analyzed interim after 72 weeks of treatment with semaglutide at a dose of 2.4 mg subcutaneously weekly or placebo (2:1)